Download Use and effectiveness of Ozoile® in Vulvovagi® spray in

Use and effectiveness of Ozoile® in Vulvovagi® spray in the treatment of
phlogosis of female genital
Clinical Protocol Doct. Maria Paola Bagella – Family Counseling ASL n 1 Sassari
The Doct. Maria Paola Bagella, gynecologist at family Counseling of ASL n 1 Sassari
(Sardinia-Italy), developed the following clinical Protocol, after the successful use of
Vulvovagi® spray in the treatment of phlogosis of female genital (vulvar and vaginal
level), including those caused by viruses (especially HPV), bacteria and mycetes
The present clinical Protocol is used and appreciated by patients which have an
appropriate compliance in case of HPV infection with or without cervical dysplasias:
- 1 / 2 endovaginal spray in the morning and 1 / 2 endovaginal spray in the evening for
10 days a month (post-menstrual period in fertile patients) for three months.
- in the acute infections, such as vaginitis, the treatment may be more concentrated, for
a limited period, for example 1 / 3 endovaginal spray 2-4 times a day for 7 – 10 days
in the opinion of attending physician.